Search results
Results from the WOW.Com Content Network
A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana rescheduling proposal pending appeals, effectively kicking the process to the ...
On December 17, 2009, Rev. Bryan A. Krumm, CNP, filed a rescheduling petition for Cannabis with the DEA arguing that "because marijuana does not have the abuse potential for placement in Schedule I of the CSA, and because marijuana now has accepted medical use in 13 states, and because the DEA's own Administrative Law Judge has already ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
The Biden administration moved Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, a historic move that acknowledges the medical benefits of ...
By rescheduling cannabis, the drug would now be studied and researched to identify concrete medical benefits, opening the door for pharmaceutical companies to get involved with the sale and ...
The Federal administrative process that began with President Biden's directive in 2022, and in 2023 with a recommendation by the Department of Health and Human Services to reschedule cannabis to Schedule III of the Controlled Substances Act was incomplete at the beginning of 2024. [1]
Cannabis remains illegal in the U.S., and it's likely to stay that way for the foreseeable future.
HR 610, the "Marijuana 1-to-3 Act" to reschedule cannabis to Schedule III of the Controlled Substances Act was introduced by Greg Steube (R) on January 27. It was referred the Committee on Energy and Commerce. [6] The Industrial Hemp Act was introduced on March 23 by Jon Tester (D) and Mike Braun (R).